NCT00370435View on ClinicalTrials.gov

Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA)

PHASE2CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

GW274150

Trial Locations (1)

W6 8LH

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00370435 - Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA) | Biotech Hunter | Biotech Hunter